Norgestrel impurity H CRS

cas: 20402-55-5 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

Norgestrel impurity H CRS (CAS 20402-55-5) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: -. Oferty producentów: Sigma-Aldrich.

producentSigma-Aldrich
nr katalogowyY0002438
cas20402-55-5
Potrzebujesz dodatkowych informacji?

Zadaj nam pytanie o ten produkt — chętnie pomożemy.

Dostępne opakowania

producent opakowanie cena
Sigma-Aldrich - 700,10 Pln
Wzór strukturalny: {0} (CAS {1})

(5S,8R,9R,10S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-one (CAS 20402-55-5) to związek chemiczny o wzorze sumarycznym C21H30O2 i masie molowej 314.5 g/mol. Nazwa systematyczna IUPAC: (5S,8R,9R,10S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-one. InChIKey: BMVIRDJAPBCAPQ-WQGSDSCCSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O2
Masa molowa314.5 g/mol
Nazwa IUPAC(5S,8R,9R,10S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-one
InChIKeyBMVIRDJAPBCAPQ-WQGSDSCCSA-N
SMILESCC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CC[C@@H]4[C@@H]3CCC(=O)C4

Dane obliczone przez PubChem (NCBI)

Synonimy: 5alpha-Dihydrolevonorgestrel, 18,19-Dinorpregn-20-yn-3-one, 13-ethyl-17-hydroxy-, (5alpha,17alpha)-, 5-alfa-Dihydrolevonorgestrel, 5alpha-dihydro Levonorgestrel, 5a-Dihydrolevonorgestrel, Norgestrel Impurity 2, 5|A-Dihydro levonorgestrel, 4,5-Didehydrolevonorgestrel, 5??-dihydro Levonorgestrel, orb1692711
Powiązane formy tego związku
(5S,8R,9R,10S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-one C21H30O2
Izomery (ten sam wzór sumaryczny)
1-[(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H30O2
methyl (1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate C21H30O2
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
[(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C21H30O2
(8R,9S,13S,14S,17S)-13-methyl-3-propoxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-ol C21H30O2
4-[(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]benzene-1,2-diol C21H30O2
(8S,9R,10S,13S,14S,17S)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C21H30O2
(6aR,10aS)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol C21H30O2
2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol C21H30O2
(8S,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O2
[(3S,8S,9S,10R,14S)-10,17-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O2